Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DTC

Defence Therapeutics (DTC)

Defence Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:CSE:DTC
DateTimeSourceHeadlineSymbolCompany
02/16/202210:00AMInvestorsHub NewsWireDEFENCE RETAINS CATO SMS TO ADVISE ON ITSĀ  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCERCSE:DTCDefence Therapeutics Inc
01/26/20228:49AMInvestorsHub NewsWireDefence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9CSE:DTCDefence Therapeutics Inc
11/30/202112:32PMInvestorsHub NewsWireDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENTCSE:DTCDefence Therapeutics Inc
11/23/20218:24AMInvestorsHub NewsWireDEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCERCSE:DTCDefence Therapeutics Inc
11/09/202111:50AMInvestorsHub NewsWireDEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORSCSE:DTCDefence Therapeutics Inc
11/03/20218:11AMInvestorsHub NewsWireVACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITSCSE:DTCDefence Therapeutics Inc
10/13/20219:15AMInvestorsHub NewsWireDEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCERCSE:DTCDefence Therapeutics Inc
10/06/20219:32AMInvestorsHub NewsWireDEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMACSE:DTCDefence Therapeutics Inc
09/29/20218:30AMInvestorsHub NewsWireDEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCERCSE:DTCDefence Therapeutics Inc
09/20/202110:01AMInvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALSCSE:DTCDefence Therapeutics Inc
09/14/20218:13AMInvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODELCSE:DTCDefence Therapeutics Inc
09/07/20217:35AMInvestorsHub NewsWireDEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATEDCSE:DTCDefence Therapeutics Inc
09/01/202110:39AMInvestorsHub NewsWireThe vaccination specialist is about to become popularCSE:DTCDefence Therapeutics Inc
 Showing the most relevant articles for your search:CSE:DTC

Your Recent History

Delayed Upgrade Clock